Although CD300a expression is primarily restricted to hematopoietic cells such as monocytes, macrophages, and dendritic cells, as confirmed by databases including the Human Protein Atlas, several studies have investigated its potential roles within the tumor immune microenvironment of solid tumors. Here, CD300A is linked to neoplasm.